Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Interstitial lung disease in scleroderma
Barbara White
Current Rheumatology Reports
|
March 14, 2002
Evaluation and management of pulmonary fibrosis in scleroderma
Barbara White
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship
|
April 24, 2013
Nurses Christian Fellowship International: Partners in Care
Barbara White
Cytokine & Growth Factor Reviews
|
October 18, 2003
Cytokine regulation of pulmonary fibrosis in scleroderma
Sergei P Atamas, Barbara White
Current Opinion in Rheumatology
|
October 22, 2003
The role of chemokines in the pathogenesis of scleroderma
Sergei P Atamas, Barbara White
The Journal of Nursing Education
|
February 18, 2011
Cognitive tools as a scaffold for faculty during curriculum redesign
Debra Hagler, Barbara White, Brenda Morris
Transplantation
|
July 23, 2009
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease
Douglas Adkins, Voravit Ratanatharathorn, Harry Yang, et al.
Nursing & Health Sciences
|
March 21, 2009
Comparison of the clinical practice satisfaction of nursing students in Korea and the USA
Chung Yul Lee, Barbara White, Yoon Mi Hong
The Journal of Rheumatology
|
January 6, 2006
Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
Boulos Haraoui, Louise Cameron, Michèle Ouellet, et al.
Clinical Therapeutics
|
May 19, 2009
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers
Barbara White, Francisco Leon, Wendy White, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Interstitial lung disease in scleroderma
Barbara White
Current Rheumatology Reports
|
March 14, 2002
Evaluation and management of pulmonary fibrosis in scleroderma
Barbara White
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship
|
April 24, 2013
Nurses Christian Fellowship International: Partners in Care
Barbara White
Cytokine & Growth Factor Reviews
|
October 18, 2003
Cytokine regulation of pulmonary fibrosis in scleroderma
Sergei P Atamas, Barbara White
Current Opinion in Rheumatology
|
October 22, 2003
The role of chemokines in the pathogenesis of scleroderma
Sergei P Atamas, Barbara White
The Journal of Nursing Education
|
February 18, 2011
Cognitive tools as a scaffold for faculty during curriculum redesign
Debra Hagler, Barbara White, Brenda Morris
Transplantation
|
July 23, 2009
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease
Douglas Adkins, Voravit Ratanatharathorn, Harry Yang, et al.
Nursing & Health Sciences
|
March 21, 2009
Comparison of the clinical practice satisfaction of nursing students in Korea and the USA
Chung Yul Lee, Barbara White, Yoon Mi Hong
The Journal of Rheumatology
|
January 6, 2006
Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
Boulos Haraoui, Louise Cameron, Michèle Ouellet, et al.
Clinical Therapeutics
|
May 19, 2009
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers
Barbara White, Francisco Leon, Wendy White, et al.
Page
of 8